Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease

被引:10
|
作者
Babulal, Ganesh M. [1 ,2 ,3 ,4 ]
Chen, Ling [5 ]
Doherty, Jason M. [1 ]
Murphy, Samantha A. [1 ]
Johnson, Ann M. [6 ]
Roe, Catherine M. [1 ]
机构
[1] Washington Univ, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Inst Publ Hlth, St Louis, MO 63110 USA
[3] Univ Johannesburg, Fac Humanities, Dept Psychol, Johannesburg, South Africa
[4] George Washington Univ, Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC 20052 USA
[5] Washington Univ, Div Biostat, St Louis, MO 63110 USA
[6] Washington Univ, Ctr Clin Studies, St Louis, MO 63110 USA
关键词
Alzheimer's disease; anger; anxiety; biomarkers; cerebrospinal fluid; older adults; MILD BEHAVIORAL IMPAIRMENT; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; OLDER-ADULTS; DEMENTIA; TAU; NEURODEGENERATION; PREVALENCE; PROFILE; DECLINE;
D O I
10.3233/JAD-215708
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) studies in cognitively normal (CN) older adults age >= 65 suggest depression is associated with molecular biomarkers (imaging and cerebrospinal fluid [CSF]). This study used linear mixed models (covariance pattern model) to assess whether baseline CSF biomarkers (A beta(42)/A beta(40), t-Tau/A beta(42) , p-Tau/A beta(42)) predicted changes in non-depressed mood states in CN older adults (N= 248), with an average of three follow-up years. Participants with higher levels of CSF biomarkers developed more anger, anxiety, and fatigue over time compared to those with more normal levels. Non-depressed mood states in preclinical AD may be a prodrome for neuropsychiatric symptoms in symptomatic AD.
引用
收藏
页码:141 / 148
页数:8
相关论文
共 50 条
  • [21] Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly
    Randall, Catherine
    Mosconi, Lisa
    De Leon, Mony
    Glodzik, Lidia
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1150 - 1173
  • [22] Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?
    Zetterberg, Henrik
    Blennow, Kaj
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S361 - S369
  • [23] Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
    Huynh, Rose Ann
    Mohan, Chandra
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [24] Cerebrospinal fluid biomarkers for pathological processes in Alzheimer's disease
    Rosen, Christoffer
    Zetterberg, Henrik
    CURRENT OPINION IN PSYCHIATRY, 2013, 26 (03) : 276 - 282
  • [25] Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease
    Zetterberg, Henrik
    Lunn, Michael P.
    Herukka, Sanna-Kaisa
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 371 - 376
  • [26] Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Present and the Future
    Ghidoni, Roberta
    Benussi, Luisa
    Paterlini, Anna
    Albertini, Valentina
    Binetti, Giuliano
    Emanuele, Enzo
    NEURODEGENERATIVE DISEASES, 2011, 8 (06) : 413 - 420
  • [27] The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer’s Disease
    Sebastiaan Engelborghs
    Nathalie Le Bastard
    Molecular Diagnosis & Therapy, 2012, 16 : 135 - 141
  • [28] Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease
    Fagan, Anne M.
    Perrin, Richard J.
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 455 - 476
  • [29] Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer's disease
    Pena-Bautista, Carmen
    Alvarez-Sanchez, Lourdes
    Pascual, Rosa
    Jose Moreno, Maria
    Baquero, Miguel
    Chafer-Pericas, Consuelo
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (03)
  • [30] MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease
    Lusardi, Theresa A.
    Phillips, Jay I.
    Wiedrick, Jack T.
    Harrington, Christina A.
    Lind, Babett
    Lapidus, Jodi A.
    Quinn, Joseph F.
    Saugstad, Julie A.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (03) : 1223 - 1233